Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Equivalent outcome of patients with clinical Stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection.
Taylor NA, Liao ZX, Cox JD, Stevens C, Roth J, Walsh G, Chang JY, Guerrero T, Jeter M, Putnam J Jr, Fossella FV, Allen P, Komaki R. Taylor NA, et al. Among authors: jeter m. Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):204-12. doi: 10.1016/s0360-3016(03)01575-x. Int J Radiat Oncol Biol Phys. 2004. PMID: 14697440
Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.
Zhang Z, Liao Z, Jin J, Ajani J, Chang JY, Jeter M, Guerrero T, Stevens CW, Swisher S, Ho L, Yao J, Allen P, Cox JD, Komaki R. Zhang Z, et al. Among authors: jeter m. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):656-64. doi: 10.1016/j.ijrobp.2004.06.022. Int J Radiat Oncol Biol Phys. 2005. PMID: 15708243
A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
Liao Z, Komaki R, Milas L, Yuan C, Kies M, Chang JY, Jeter M, Guerrero T, Blumenschien G, Smith CM, Fossella F, Brown B, Cox JD. Liao Z, et al. Among authors: jeter m. Clin Cancer Res. 2005 May 1;11(9):3342-8. doi: 10.1158/1078-0432.CCR-04-1741. Clin Cancer Res. 2005. PMID: 15867233 Clinical Trial.
Treatment planning system evaluation for mesothelioma IMRT.
Stevens CW, Wong PF, Rice D, Jeter M, Forster K, Zhu XR. Stevens CW, et al. Among authors: jeter m. Lung Cancer. 2005 Jul;49 Suppl 1:S75-81. doi: 10.1016/j.lungcan.2005.03.023. Lung Cancer. 2005. PMID: 15950806
Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer.
Shioyama Y, Jang SY, Liu HH, Guerrero T, Wang X, Gayed IW, Erwin WD, Liao Z, Chang JY, Jeter M, Yaremko BP, Borghero YO, Cox JD, Komaki R, Mohan R. Shioyama Y, et al. Among authors: jeter m. Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1349-58. doi: 10.1016/j.ijrobp.2007.02.015. Epub 2007 Apr 18. Int J Radiat Oncol Biol Phys. 2007. PMID: 17446001
Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.
Rice DC, Smythe WR, Liao Z, Guerrero T, Chang JY, McAleer MF, Jeter MD, Correa A, Vaporciyan AA, Liu HH, Komaki R, Forster KM, Stevens CW. Rice DC, et al. Among authors: jeter md. Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):350-7. doi: 10.1016/j.ijrobp.2007.03.011. Epub 2007 Apr 30. Int J Radiat Oncol Biol Phys. 2007. PMID: 17467922
82 results